Table 1 Univariate correlation between serum AZGP1 and other variables
From: Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease
| Â | AKI | AKI follow-up | ||
|---|---|---|---|---|
n = 21 | n = 21 | |||
|  | Median (quantiles) | Spearmans’ coefficient; p-value | Median (quantiles) | Spearmans’ coefficient; p-value |
creatinine (μmol/l) | 290 (218–409) | r = 0.093; p = 0.696 | 101 (79–132) | r = 0.776; p = <0.001 |
eGFR (ml/min) | 16 (10.5 - 30) | r = −0.176; p = 0.458 | 52 (44–81) | r = −0.777; p = <0.001 |
urea (mmol/l) | 15.8 (1.9 - 28.5) | r = 0.144; p = 0.546 | 7.6 (5.3 - 9.9) | r = 0.659; p = 0.002 |
LDH (U/l) | 1311 (871–1791) | r = −0.168; p = 0.478 | 192 (171–237) | r = 0.887; p = < 0.0001 |
CRP (mg/l) | 40.3 (21.8 - 101.8) | r = −0.104; p = 0.663 | 1 (1–6.5) | r = 0.62; p = 0.048 |
AST (U/l) | 68 (58–89) | r = −0.139; p = 0.621 | 23 (20–26.5) | r = 0.49; p = 0.064 |
ALT (U/l) | 32.5 (23–47.5) | r = −0.075; p = 0.775 | 17 (12–23.5) | r = 0.67; p = 0.006 |
leukocytes (103/μl) | 14.8 (8.8 - 19.6) | r = 0.390; p = 0.089 | 5.6 (4.8 - 6.7) | r = 0.455; p = 0.044 |